Quantitative Factors and Construction Methods - **Factor Name**: Large Order Transaction Amount Ratio **Factor Construction Idea**: This factor captures the buying behavior of large capital by analyzing the proportion of large order transaction amounts in the total daily transaction amount[8] **Factor Construction Process**: 1. Use tick-by-tick transaction data to identify buy and sell orders based on the sequence numbers of bids and asks 2. Filter transactions by order size to identify large orders 3. Calculate the proportion of large buy order transaction amounts in the total daily transaction amount **Formula**: $ \text{Large Order Transaction Amount Ratio} = \frac{\text{Large Buy Order Transaction Amount}}{\text{Total Daily Transaction Amount}} $ **Evaluation**: This factor effectively reflects the buying behavior of large capital[8] - **Factor Name**: Net Active Buy Transaction Amount Ratio **Factor Construction Idea**: This factor measures the active buying behavior of investors by calculating the net active buy transaction amount as a proportion of the total daily transaction amount[8] **Factor Construction Process**: 1. Use tick-by-tick transaction data to classify each transaction as either active buy or active sell based on the buy/sell indicator 2. Subtract the active sell transaction amount from the active buy transaction amount to obtain the net active buy transaction amount 3. Calculate the proportion of the net active buy transaction amount in the total daily transaction amount **Formula**: $ \text{Net Active Buy Transaction Amount Ratio} = \frac{\text{Active Buy Transaction Amount} - \text{Active Sell Transaction Amount}}{\text{Total Daily Transaction Amount}} $ **Evaluation**: This factor provides insights into the active buying tendencies of investors[8] --- Factor Backtesting Results - **Large Order Transaction Amount Ratio**: - Top 10 stocks with the highest 5-day average values: 1. Hanjiang Heshan (603616.SH): 93.5%, 99.2% time-series percentile[10] 2. Minbao Optoelectronics (301362.SZ): 89.7%, 98.4% time-series percentile[10] 3. Hangdian Co., Ltd. (603618.SH): 86.1%, 99.6% time-series percentile[10] 4. Jinzhengda (002470.SZ): 85.2%, 83.9% time-series percentile[10] 5. Guofa Co., Ltd. (600538.SH): 84.9%, 92.4% time-series percentile[10] 6. Shunna Co., Ltd. (000533.SZ): 84.7%, 100.0% time-series percentile[10] 7. Quanzhu Co., Ltd. (603030.SH): 84.6%, 94.4% time-series percentile[10] 8. Beijing Investment Development (600683.SH): 84.5%, 96.0% time-series percentile[10] 9. Chongqing Steel (601005.SH): 84.3%, 52.2% time-series percentile[10] 10. Huadian International (600027.SH): 83.6%, 95.2% time-series percentile[10] - **Net Active Buy Transaction Amount Ratio**: - Top 10 stocks with the highest 5-day average values: 1. Minsheng Bank (600016.SH): 21.1%, 100.0% time-series percentile[11] 2. Kairuide (002072.SZ): 20.3%, 99.6% time-series percentile[11] 3. Intercontinental Oil & Gas (600759.SH): 19.5%, 100.0% time-series percentile[11] 4. Boen Group (001366.SZ): 17.8%, 100.0% time-series percentile[11] 5. Bowan Technology (600883.SH): 17.5%, 99.6% time-series percentile[11] 6. Xiangyou Technology (600476.SH): 16.8%, 99.2% time-series percentile[11] 7. Zhejiang Commercial Bank (601916.SH): 16.8%, 94.4% time-series percentile[11] 8. General Elevator (300931.SZ): 15.9%, 100.0% time-series percentile[11] 9. Weier Pharmaceutical (603351.SH): 15.3%, 94.0% time-series percentile[11] 10. Ruierte (002790.SZ): 15.2%, 98.4% time-series percentile[11]

Group 1 - The stock price of Tongyuan Petroleum (300164) closed at 11.74 yuan on February 10, 2026, down 3.45%, with a turnover rate of 25.45% and a trading volume of 1.4843 million hands, resulting in a transaction amount of 1.772 billion yuan [1] - On February 10, the net outflow of main funds was 153 million yuan, accounting for 8.64% of the total transaction amount, while retail investors had a net inflow of 132 million yuan, representing 7.45% of the total transaction amount [1][2] - For the first three quarters of 2025, Tongyuan Petroleum reported a main revenue of 860 million yuan, a year-on-year decrease of 0.82%, and a net profit attributable to shareholders of 56.22 million yuan, an increase of 16.84% year-on-year [2] Group 2 - In Q3 2025, the company's single-quarter main revenue was 308 million yuan, down 2.31% year-on-year, while the single-quarter net profit attributable to shareholders was 17.59 million yuan, up 31.16% year-on-year [2] - The company's debt ratio stands at 27.74%, with investment income of 1.53 million yuan and financial expenses of 2.84 million yuan, resulting in a gross profit margin of 25.04% [2]

Market Overview - In January 2026, global funds saw a significant outflow from emerging markets, with China experiencing a notable decline in fund allocation[3] - The Brent crude oil price increased by 14.6%, while industrial and precious metals saw substantial gains, with LME nickel, copper, and aluminum rising over 10%[3] - The U.S. equity market attracted $44.9 billion, while non-U.S. equity markets only saw an inflow of $2.3 billion during the same period[12] Fund Flows - China’s equity market experienced an outflow of $96.2 billion in January, while the fixed income market saw a $17 billion outflow[25] - Active funds contributed $2.1 billion to the Chinese equity market, whereas passive funds saw a significant outflow of $98.2 billion[22] - The relative outflow ratios for Chinese fixed income and equity funds reached 11.0% and 7.2%, respectively, indicating a higher outflow compared to other major markets[22] Global Asset Allocation - As of December 2025, the global allocation to U.S. equities slightly decreased to 61.2%, while the allocation to Chinese equities was at a historical low of 31.5%[3] - Emerging markets reduced their allocation to Chinese equities, with the current allocation ratio at 37.7%, reflecting a downward trend[3] Risk Factors - Short-term asset price fluctuations may not accurately represent long-term trends, and potential economic downturns in Europe and the U.S. could impact market stability[3]

Core Viewpoint - The stock of Aojing Medical (688613) has shown a significant increase, closing at 24.17 yuan on February 9, 2026, with an 8.58% rise, indicating positive market sentiment towards the company [1]. Group 1: Stock Performance - On February 9, 2026, Aojing Medical's trading volume was 79,600 hands, with a total transaction amount of 189 million yuan [1]. - The stock's turnover rate was 5.81%, reflecting active trading [1]. Group 2: Capital Flow - On February 9, 2026, the net inflow of main funds was 2.45 million yuan, accounting for 1.29% of the total transaction amount, while retail investors saw a net inflow of 2.69 million yuan, representing 1.42% of the total [1]. - Over the past five days, the financing data showed a net purchase of 1.41 million yuan on that day, with a cumulative net purchase of 5.72 million yuan over three days [2]. Group 3: Financial Performance - For the first three quarters of 2025, Aojing Medical reported a main revenue of 156 million yuan, a year-on-year increase of 5.22%, and a net profit attributable to shareholders of 13.94 million yuan, up 185.19% [3]. - In the third quarter of 2025, the company achieved a single-quarter main revenue of 56.02 million yuan, a 16.54% increase year-on-year, and a net profit of 5.97 million yuan, reflecting a 237.64% rise [3]. - The company's gross profit margin stood at 68.9%, indicating strong profitability in its operations [3].

Group 1 - The stock price of Jiacheng International (603535) closed at 10.08 yuan on February 9, 2026, with an increase of 0.9% and a turnover rate of 0.5% [1] - The net inflow of main funds on February 9 was 1.482 million yuan, accounting for 5.82% of the total transaction amount, while retail investors had a net outflow of 1.1993 million yuan, accounting for 4.71% [1] - Over the past five days, the stock has experienced fluctuations in fund flows, with significant net outflows from retail investors on several days [1] Group 2 - Jiacheng International's total market value is 5.15 billion yuan, which is below the logistics industry average of 16.968 billion yuan, ranking 30th out of 55 [2] - The company's net profit for the first three quarters of 2025 was 149 million yuan, a decrease of 10.41% year-on-year, with a third-quarter net profit of 30.5074 million yuan, down 36.62% year-on-year [2] - The gross profit margin of Jiacheng International is 32.56%, significantly higher than the industry average of 14.16%, ranking 5th out of 55 [2]

Group 1 - The core point of the article indicates that the main silver futures contract (2604) has increased by 7.99%, reaching 20,698 yuan per kilogram, with a notable reduction in positions by 10,104 contracts, reflecting a decrease of 4.45% compared to the previous day [1] - The net inflow of funds for the day is reported at 366 million yuan, suggesting a positive sentiment in the market despite the reduction in positions [1] - The article highlights the importance of monitoring position changes as they reflect the competition between bulls and bears, and significant changes can indicate market trends [4] Group 2 - The data shows a consistent reduction in positions throughout the day, with a decrease of 5.4% reported earlier, indicating a trend of diminishing holdings [3] - The article emphasizes the need for comprehensive analysis by combining position changes with other indicators such as price trends and volume changes to assess market direction [4] - The functionality of the position change feature in the Jin Investment Network app is designed to help users stay informed about market dynamics, which can aid in making informed investment decisions [4]

Group 1: Global Asset Market Performance - The latest yields of 10 - year government bonds in major economies: US 4.208, UK 4.514, France 3.446, Germany 2.841, Italy 3.466, Spain 3.220, Switzerland 0.243, Greece 3.454, Japan 2.222, Brazil 6.169, China 1.806, South Korea 3.697, Australia 4.826, New Zealand 4.535 [3] - The latest yields of 2 - year government bonds in major economies: US 3.500, UK 3.617, Germany 2.082, Japan 1.275, Italy 2.231, China (1Y yield) 1.308, South Korea 3.009, Australia 4.254 [3] - The latest exchange rates of the US dollar against major emerging - economy currencies: Brazil 5.219, Russia (not provided), South Africa zar 16.031, Korean won 1463.650, Thai baht 31.647, Malaysian ringgit 3.948 [3] - The latest exchange rates related to the RMB: on - shore RMB 6.936, off - shore RMB 6.930, RMB central parity rate 6.959, RMB 12 - month NDF 6.797 [3] - The latest values of major economies' stock indices: S&P 500 6932.300, Dow Jones Industrial Index 50115.670, Nasdaq 23031.210, Mexican stock index 70809.570, UK stock index 10369.750, France CAC 8273.840, Germany DAX 24721.460, Spanish stock index 17943.300, Russian stock index (not provided), Nikkei 54253.680, Hang Seng Index 26559.950, Shanghai Composite Index 4065.583, Taiwan stock index 31782.920, South Korean stock index 5089.140, Indian stock index 7935.260, Thai stock index 1354.010, Malaysian stock index 1732.830, Australian stock index 8954.613, emerging - economy stock index 1506.380 [3] - The latest values of credit - bond indices: US investment - grade credit - bond index 3560.630, euro - zone investment - grade credit - bond index 267.879, emerging - economy investment - grade credit - bond index 290.940, US high - yield credit - bond index 2932.470, euro - zone high - yield credit - bond index 413.420, emerging - economy high - yield credit - bond index 1848.064 [3] Group 2: Stock Index Futures Trading Data - Index performance: A - share closing price 4065.58 (down 0.25%), CSI 300 closing price 4643.60 (down 0.57%), SSE 50 closing price 3037.86 (down 0.69%), ChiNext closing price 3236.46 (down 0.73%), CSI 500 closing price 8146.41 (unchanged) [4] - Valuation: PE(TTM) of CSI 300 14.04 (down 0.04), SSE 50 11.59 (down 0.05), CSI 500 36.90 (down 0.02), S&P 500 27.68 (up 0.53), Germany DAX 19.18 (up 0.18) [4] - Risk premium: 1/PE - 10 - year interest rate of S&P 500 - 0.60 (down 0.10), Germany DAX 2.37 (down 0.05) [4] - Fund flow: A - share latest value 202.42, main - board latest value 114.74, small - and - medium - enterprise board (not provided), ChiNext latest value 71.02, CSI 300 latest value - 34.69; A - share 5 - day average - 272.73, main - board 5 - day average - 179.44, small - and - medium - enterprise board (not provided), ChiNext 5 - day average - 60.47, CSI 300 5 - day average - 37.58 [4] - Transaction amount: Shanghai and Shenzhen stock markets latest value 21457.19 (down 305.01), CSI 300 latest value 5057.60 (down 446.73), SSE 50 latest value 1336.06 (down 143.91), small - cap board latest value 4650.31 (up 273.12), ChiNext latest value 5607.18 (up 84.29) [5] - Main contract basis and spread: IF basis - 6.00 (spread - 0.13%), IH basis - 1.66 (spread - 0.05%), IC basis - 29.01 (spread - 0.36%) [5] Group 3: Treasury Bond Futures Trading Data - Treasury bond futures closing prices: T2303 108.42 (up 0.09%), TF2303 105.95 (up 0.03%), T2306 108.44 (up 0.10%), TF2306 106.02 (up 0.07%) [5] - Fund rates: R001 1.3605% (down 19.00 BP), R007 1.5288% (down 2.00 BP), SHIBOR - 3M 1.5800% (unchanged) [5]

01 涨跌速览 本周 股市场整体承压运行，主要指数普遍收跌，结构性分化特征进一步加剧。 数据显示，全市场 41 个主要指数中仅有 2 个实现周度上涨，其余指数 不同程度下行。科创 50 、创业板指跌幅居前，大盘价值风格相对稳健，小微盘股跌势有所放缓，而中盘股成为本轮调整的重点区域。 从市场整体表现看，本周并未出现系统性恐慌性下跌，但风险偏好持续回落，节前资金谨慎特征显著。 行业层面，本周 A 股延续明显轮动特征。 日常消费、工业等防御性和早周期板块表现相对占优，成为资金阶段性避险的重要方向；与此同时，信息技 术、材料等前期涨幅较大的成长板块出现明显回调，科技与资源类板块调整压力集中释放。 个股层面，周涨幅居前的标的以超跌小盘股和部分消费防御类个股为主 ；而周跌幅榜中，贵金属、科技板块个股集中回调，此前高估值、高弹性方向的 去风险过程仍在延续。 户 外 缩量缓跌、情绪筑底, 节前市场进入防守与观望阶段 行业轮动:消费防御领涨, 成长板块深度回调体调整 本周A股行业轮动日常消费、工业等防御性与早周期板 块领涨,信息技术、材料等前期热门成长板块大幅回调。 行业周涨跌幅 (%) 2026.02.02 - 2026.0 ...

Core Viewpoint - The stock of Shangrong Medical (002551) has shown fluctuations in trading activity, with a recent closing price of 3.86 yuan, reflecting a slight increase of 0.26% on February 6, 2026, amidst mixed capital flows [1][2]. Group 1: Stock Performance and Trading Activity - On February 6, 2026, Shangrong Medical's stock closed at 3.86 yuan, with a trading volume of 102,500 hands and a total transaction amount of 39.6174 million yuan [1]. - The capital flow data indicates a net outflow of 713,100 yuan from main funds, accounting for 1.8% of the total transaction amount, while retail investors saw a net inflow of 2.1746 million yuan, representing 5.49% of the total [1][2]. Group 2: Recent Capital Flow Trends - Over the past five days, the stock has experienced varying capital flows, with notable net outflows from main and speculative funds on several days, while retail investors consistently showed net inflows [2]. - The detailed capital flow for February 6, 2026, shows a net outflow of 713,100 yuan from main funds and 1.4615 million yuan from speculative funds, contrasted by a net inflow of 2.1746 million yuan from retail investors [2]. Group 3: Company Financial Metrics and Industry Comparison - Shangrong Medical's total market capitalization is 3.264 billion yuan, with a net asset value of 2.73 billion yuan, and a net profit of -35.1253 million yuan, indicating a challenging financial position compared to the industry averages [3]. - The company's gross margin stands at 14.35%, significantly lower than the industry average of 50.55%, and its net profit margin is -4.6%, compared to the industry average of 9.59% [3]. - Shangrong Medical's return on equity (ROE) is -1.34%, which is below the industry average of 0.42%, highlighting its underperformance in profitability metrics [3].

Group 1 - The core viewpoint of the news is that Lehui International (603076) has shown mixed financial performance in its recent quarterly report, with a slight increase in revenue but a significant decline in net profit [2] - As of February 6, 2026, Lehui International's stock closed at 24.9 yuan, with a slight increase of 0.48% and a trading volume of 12,900 hands, amounting to a total transaction value of 32.1347 million yuan [1] - In the recent funding flow data, the main funds experienced a net outflow of 0.45 thousand yuan, while retail investors saw a net inflow of 118.74 thousand yuan, indicating differing investor behaviors [1] Group 2 - For the first three quarters of 2025, Lehui International reported a main operating income of 950 million yuan, a year-on-year increase of 0.28%, while the net profit attributable to shareholders decreased by 17.1% to 33.6006 million yuan [2] - The third quarter of 2025 saw a significant increase in operating income to 334 million yuan, up 20.89% year-on-year, but the net profit attributable to shareholders dropped by 56.51% to 7.9642 million yuan [2] - The company has a debt ratio of 62.97%, with investment income of 2.7412 million yuan and financial expenses of 8.1734 million yuan, resulting in a gross profit margin of 25.22% [2]